NCT06435403View on ClinicalTrials.gov

SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 10, 2022

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
SARS CoV 2 InfectionCOVID-19 BreakthroughCOVID-19 Recurrent
Trial Locations (2)

Unknown

RECRUITING

Department of Microbiology Immunology and Parasitology, Addis Ababa

RECRUITING

Jimma University, Jimma

All Listed Sponsors
collaborator

St. Paul's Hospital Millennium Medical College, Ethiopia

OTHER

collaborator

Jimma University

OTHER

lead

Michael Hoelscher

OTHER